November was a historic month for stocks-- the Dow was up about 11.8% for the month, the S&P 500 rose 10.8% while the Nasdaq gained 11.8%. Unlike earlier this year, when the rally was led mainly by mega-cap tech stocks, economically sensitive areas emerged as the biggest winners last month. The small-cap Russell 2000 index surged about 18.3% -- its best monthly gain ever.
The widening of rally was thanks mainly to very encouraging vaccine trial results from Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) and AstraZeneca (AZN - Free Report) . Hopes that the presidential transition would be smooth have also boosted investor sentiment. Additionally, nomination of Janet Yellen for Treasury secretary has reignited hopes of a large stimulus next year, which would benefit smaller companies a lot.
To learn more the iShares Russell 2000 ETF (IWM - Free Report) , the iShares Core S&P Small-Cap ETF (IJR - Free Report) and the Vanguard Small Cap Growth ETF (VBK - Free Report) that soared in November, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
November was a historic month for stocks-- the Dow was up about 11.8% for the month, the S&P 500 rose 10.8% while the Nasdaq gained 11.8%. Unlike earlier this year, when the rally was led mainly by mega-cap tech stocks, economically sensitive areas emerged as the biggest winners last month. The small-cap Russell 2000 index surged about 18.3% -- its best monthly gain ever.
The widening of rally was thanks mainly to very encouraging vaccine trial results from Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) and AstraZeneca (AZN - Free Report) . Hopes that the presidential transition would be smooth have also boosted investor sentiment. Additionally, nomination of Janet Yellen for Treasury secretary has reignited hopes of a large stimulus next year, which would benefit smaller companies a lot.
To learn more the iShares Russell 2000 ETF (IWM - Free Report) , the iShares Core S&P Small-Cap ETF (IJR - Free Report) and the Vanguard Small Cap Growth ETF (VBK - Free Report) that soared in November, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AZN - FREE
Get the latest research report on PFE - FREE
Get the latest research report on MRNA - FREE
Get the latest research report on IWM - FREE
Get the latest research report on IJR - FREE
Get the latest research report on VBK - FREE